Pressemitteilung BoxID: 769362 (BIOTRONIK)
  • Woermannkehre 1
  • 12359 Berlin
  • Ansprechpartner
  • Manuela Schildwächter
  • +49 (30) 689051414

BIOTRONIK and Cardiology Experts Support Heartbeat International in Top Education

Company Links Heartbeat International with Globally Celebrated Cardiologists for Scientific Symposium at this Year's Interamerican Congress of Cardiology

(PresseBox) (Lake Oswego, Oregon and SANTIAGO, Chile, ) BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, will put its charity partner Heartbeat International (HBI) on the world stage of cardiology education at the 25th Interamerican Congress of Cardiology (ICC) in Santiago, Chile.

Some of the most renowned cardiology experts in the Americas will join HBI at a symposium entitled “Advancement in Cardiac Rhythm Management.” Speaking ahead of the event, where he will address the audience on advancements in catheter-based ablation, Dr. Larry Chinitz, the Alvin Benjamin and Kenneth Coyle, Sr. Family Professor of Medicine and Cardiac Electrophysiology, Department of Medicine, at NYU Langone Medical Center said: “I’m very much looking forward to this unique educational program, which will feature an acclaimed faculty and focus on educating leaders in the field about the treatment of patients with cardiac rhythm disorders.”

Since 1984, the non-profit humanitarian organization HBI has implanted cardiac devices for disadvantaged patients in developing countries. Since 2010, BIOTRONIK has donated the vast majority of these lifesaving devices—over 5,600 in total. This year alone, the partnership is on track to save 500 lives. BIOTRONIK has furthered its support by funding the recently opened HBI Heart Center in the Dominican capital of Santo Domingo. The scientific symposium at ICC adds another dimension to the company’s support for the worthy charity.

“Cardiac arrhythmia patients, including those in the world’s poorest regions, need to feel secure in knowing that both the devices we donate and the training their implanting physicians receive is of the highest quality,” explained Marlou Janssen, President of BIOTRONIK, Inc. “This symposium brings together leading global experts on the latest technology and advancements in electrophysiology, offering both great educational value and a chance for more cardiology professionals to learn about how our partner HBI works to saves lives all over the world, which is why we’re proud to support it.”

Heartbeat International Cardiovascular Sciences Symposium @ 25th Interamerican Cardiology Congress

Advancements in Cardiac Rhythm Management

Saturday December 5 Salón Pedro de Valdivia “B”, 16:45-18:15

Chairmen: Dr. Rodrigo Miranda (Chile) and Dr. Gastón Albina (Argentina)
  • Welcome & Introduction to Heartbeat International     Speaker: HBI Staff (16:45-16:50)
  • Advancements in Catheter-Based Ablation (16:50-17:10). Speaker: Larry Chinitz, MD, Professor of Medicine and Cardiac Electrophysiology, NYU Langone Medical Center
  • Management of Idiopathic Premature Ventricular Contractions (17:10-17:30). Speaker: Dr. Rakesh Latchamsetty, Assistant Professor of Medicine, University of Michigan
  • Clinical Observations in Patients Receiving a Single-Lead Defibrillator (17:30-17:50). Speaker: Raul Weiss, MD, FACC, Professor of Clinical Medicine, Ohio State University
  • MRI Conditional Pacemakers and Defibrillators: More Choices for Patients and Physicians (17:50-18:10). Speaker: Dr. Thomas Crawford, Assistant Professor of Medicine, University of Michigan
  • Q&A: Panel (18:10-18:15).
  • Concluding Remarks/Thank You
About HBI

Heartbeat International (HBI) was founded in 1984 by Dr. Henry McIntosh from the US and Dr. Federico Alfaro from Guatemala. Over the past 31 years, HBI has grown into a world-class charitable foundation, saving 14,000 lives around the world, through its network of Heart Centers across the globe. HBI accomplishes this by providing pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices, along with all professional and medical services by doctors and hospitals, at no cost to the patient. Of the 14,000 lives HBI has saved since 1984, over 10,000 were in Latin America and the Western Hemisphere.

Website Promotion


One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world's first 4 F-compatible 200 mm peripheral stent; Orsiro, the industry's first hybrid drug-eluting stent; and the world's first implantable cardioverter-defibrillators with ProMRI® technology.

For more information, visit: